PMC:7265874 / 8713-10294 JSON TXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T17","span":{"begin":273,"end":281},"obj":"Body_part"}],"attributes":[{"id":"A17","pred":"fma_id","subj":"T17","obj":"http://purl.org/sig/ont/fma/fma264783"}],"text":"Abbreviations\nCOVID-19 Coronavirus disease 2019\nSARS-COV-2 virus Severe acute respiratory syndrome coronavirus 2\nICU Intensive care unit\nIPA Invasive pulmonary aspergillosis\nIAA Influenza-associated aspergillosis\nARDS Acute respiratory distress syndrome\nh Hour\nBAL Broncho-alveolar lavage\nCT Computed tomography\nEORTC European Organization for Research and Treatment of Cancer\nAspICU Aspergillosis intensive care unit\nNo Number\nSD Standard deviation\nHEPA High-efficiency particulate air filters\nPublisher's Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\n\nAcknowledgements\nWe want to thank our entire ICU team for their unwavering commitment during these challenging times.\n\nAuthors’ contributions\nLR wrote the first draft of manuscript with input and revisions from NVR and NS. NS collected the data from the source documents. TVH and LR performed the literature search. PB and HD advised on the reporting of the clinical data; RN and HM on the reporting of the microbiological and infection prevention data. All authors had full access to all of the data. All authors read and approved the final manuscript.\n\nFunding\nNone.\n\nAvailability of data and materials\nThe datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.\n\nEthics approval and consent to participate\nPublication approval granted by the Ethics Committee.\n\nConsent for publication\nNot applicable.\n\nCompeting interests\nThe authors declare that they have no competing interests."}

LitCovid-PD-MONDO

LitCovid-PD-CLO

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T57","span":{"begin":59,"end":64},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T58","span":{"begin":327,"end":339},"obj":"http://purl.obolibrary.org/obo/OBI_0000245"}],"text":"Abbreviations\nCOVID-19 Coronavirus disease 2019\nSARS-COV-2 virus Severe acute respiratory syndrome coronavirus 2\nICU Intensive care unit\nIPA Invasive pulmonary aspergillosis\nIAA Influenza-associated aspergillosis\nARDS Acute respiratory distress syndrome\nh Hour\nBAL Broncho-alveolar lavage\nCT Computed tomography\nEORTC European Organization for Research and Treatment of Cancer\nAspICU Aspergillosis intensive care unit\nNo Number\nSD Standard deviation\nHEPA High-efficiency particulate air filters\nPublisher's Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\n\nAcknowledgements\nWe want to thank our entire ICU team for their unwavering commitment during these challenging times.\n\nAuthors’ contributions\nLR wrote the first draft of manuscript with input and revisions from NVR and NS. NS collected the data from the source documents. TVH and LR performed the literature search. PB and HD advised on the reporting of the clinical data; RN and HM on the reporting of the microbiological and infection prevention data. All authors had full access to all of the data. All authors read and approved the final manuscript.\n\nFunding\nNone.\n\nAvailability of data and materials\nThe datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.\n\nEthics approval and consent to participate\nPublication approval granted by the Ethics Committee.\n\nConsent for publication\nNot applicable.\n\nCompeting interests\nThe authors declare that they have no competing interests."}

LitCovid-PD-CHEBI

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T106","span":{"begin":137,"end":140},"obj":"Chemical"},{"id":"T108","span":{"begin":174,"end":177},"obj":"Chemical"},{"id":"T109","span":{"begin":261,"end":264},"obj":"Chemical"},{"id":"T110","span":{"begin":428,"end":430},"obj":"Chemical"},{"id":"T111","span":{"begin":774,"end":776},"obj":"Chemical"},{"id":"T112","span":{"begin":851,"end":853},"obj":"Chemical"},{"id":"T113","span":{"begin":855,"end":857},"obj":"Chemical"},{"id":"T114","span":{"begin":912,"end":914},"obj":"Chemical"},{"id":"T115","span":{"begin":948,"end":950},"obj":"Chemical"},{"id":"T117","span":{"begin":955,"end":957},"obj":"Chemical"},{"id":"T118","span":{"begin":1012,"end":1014},"obj":"Chemical"}],"attributes":[{"id":"A106","pred":"chebi_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/CHEBI_17824"},{"id":"A107","pred":"chebi_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/CHEBI_30802"},{"id":"A108","pred":"chebi_id","subj":"T108","obj":"http://purl.obolibrary.org/obo/CHEBI_16411"},{"id":"A109","pred":"chebi_id","subj":"T109","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A110","pred":"chebi_id","subj":"T110","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A111","pred":"chebi_id","subj":"T111","obj":"http://purl.obolibrary.org/obo/CHEBI_73528"},{"id":"A112","pred":"chebi_id","subj":"T112","obj":"http://purl.obolibrary.org/obo/CHEBI_73426"},{"id":"A113","pred":"chebi_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/CHEBI_73426"},{"id":"A114","pred":"chebi_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/CHEBI_73528"},{"id":"A115","pred":"chebi_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/CHEBI_53319"},{"id":"A116","pred":"chebi_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/CHEBI_60686"},{"id":"A117","pred":"chebi_id","subj":"T117","obj":"http://purl.obolibrary.org/obo/CHEBI_73925"},{"id":"A118","pred":"chebi_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/CHEBI_74053"}],"text":"Abbreviations\nCOVID-19 Coronavirus disease 2019\nSARS-COV-2 virus Severe acute respiratory syndrome coronavirus 2\nICU Intensive care unit\nIPA Invasive pulmonary aspergillosis\nIAA Influenza-associated aspergillosis\nARDS Acute respiratory distress syndrome\nh Hour\nBAL Broncho-alveolar lavage\nCT Computed tomography\nEORTC European Organization for Research and Treatment of Cancer\nAspICU Aspergillosis intensive care unit\nNo Number\nSD Standard deviation\nHEPA High-efficiency particulate air filters\nPublisher's Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\n\nAcknowledgements\nWe want to thank our entire ICU team for their unwavering commitment during these challenging times.\n\nAuthors’ contributions\nLR wrote the first draft of manuscript with input and revisions from NVR and NS. NS collected the data from the source documents. TVH and LR performed the literature search. PB and HD advised on the reporting of the clinical data; RN and HM on the reporting of the microbiological and infection prevention data. All authors had full access to all of the data. All authors read and approved the final manuscript.\n\nFunding\nNone.\n\nAvailability of data and materials\nThe datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.\n\nEthics approval and consent to participate\nPublication approval granted by the Ethics Committee.\n\nConsent for publication\nNot applicable.\n\nCompeting interests\nThe authors declare that they have no competing interests."}

LitCovid-PD-HP

{"project":"LitCovid-PD-HP","denotations":[{"id":"T47","span":{"begin":137,"end":140},"obj":"Phenotype"},{"id":"T48","span":{"begin":141,"end":173},"obj":"Phenotype"},{"id":"T49","span":{"begin":224,"end":244},"obj":"Phenotype"},{"id":"T50","span":{"begin":370,"end":376},"obj":"Phenotype"}],"attributes":[{"id":"A47","pred":"hp_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/HP_0020103"},{"id":"A48","pred":"hp_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/HP_0020103"},{"id":"A49","pred":"hp_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A50","pred":"hp_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Abbreviations\nCOVID-19 Coronavirus disease 2019\nSARS-COV-2 virus Severe acute respiratory syndrome coronavirus 2\nICU Intensive care unit\nIPA Invasive pulmonary aspergillosis\nIAA Influenza-associated aspergillosis\nARDS Acute respiratory distress syndrome\nh Hour\nBAL Broncho-alveolar lavage\nCT Computed tomography\nEORTC European Organization for Research and Treatment of Cancer\nAspICU Aspergillosis intensive care unit\nNo Number\nSD Standard deviation\nHEPA High-efficiency particulate air filters\nPublisher's Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\n\nAcknowledgements\nWe want to thank our entire ICU team for their unwavering commitment during these challenging times.\n\nAuthors’ contributions\nLR wrote the first draft of manuscript with input and revisions from NVR and NS. NS collected the data from the source documents. TVH and LR performed the literature search. PB and HD advised on the reporting of the clinical data; RN and HM on the reporting of the microbiological and infection prevention data. All authors had full access to all of the data. All authors read and approved the final manuscript.\n\nFunding\nNone.\n\nAvailability of data and materials\nThe datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.\n\nEthics approval and consent to participate\nPublication approval granted by the Ethics Committee.\n\nConsent for publication\nNot applicable.\n\nCompeting interests\nThe authors declare that they have no competing interests."}

LitCovid-sentences

{"project":"LitCovid-sentences","denotations":[{"id":"T71","span":{"begin":0,"end":13},"obj":"Sentence"},{"id":"T72","span":{"begin":14,"end":47},"obj":"Sentence"},{"id":"T73","span":{"begin":48,"end":112},"obj":"Sentence"},{"id":"T74","span":{"begin":113,"end":136},"obj":"Sentence"},{"id":"T75","span":{"begin":137,"end":173},"obj":"Sentence"},{"id":"T76","span":{"begin":174,"end":212},"obj":"Sentence"},{"id":"T77","span":{"begin":213,"end":253},"obj":"Sentence"},{"id":"T78","span":{"begin":254,"end":260},"obj":"Sentence"},{"id":"T79","span":{"begin":261,"end":288},"obj":"Sentence"},{"id":"T80","span":{"begin":289,"end":311},"obj":"Sentence"},{"id":"T81","span":{"begin":312,"end":376},"obj":"Sentence"},{"id":"T82","span":{"begin":377,"end":417},"obj":"Sentence"},{"id":"T83","span":{"begin":418,"end":427},"obj":"Sentence"},{"id":"T84","span":{"begin":428,"end":449},"obj":"Sentence"},{"id":"T85","span":{"begin":450,"end":494},"obj":"Sentence"},{"id":"T86","span":{"begin":495,"end":511},"obj":"Sentence"},{"id":"T87","span":{"begin":512,"end":630},"obj":"Sentence"},{"id":"T88","span":{"begin":632,"end":648},"obj":"Sentence"},{"id":"T89","span":{"begin":649,"end":749},"obj":"Sentence"},{"id":"T90","span":{"begin":751,"end":773},"obj":"Sentence"},{"id":"T91","span":{"begin":774,"end":854},"obj":"Sentence"},{"id":"T92","span":{"begin":855,"end":903},"obj":"Sentence"},{"id":"T93","span":{"begin":904,"end":947},"obj":"Sentence"},{"id":"T94","span":{"begin":948,"end":1085},"obj":"Sentence"},{"id":"T95","span":{"begin":1086,"end":1133},"obj":"Sentence"},{"id":"T96","span":{"begin":1134,"end":1185},"obj":"Sentence"},{"id":"T97","span":{"begin":1187,"end":1194},"obj":"Sentence"},{"id":"T98","span":{"begin":1195,"end":1200},"obj":"Sentence"},{"id":"T99","span":{"begin":1202,"end":1236},"obj":"Sentence"},{"id":"T100","span":{"begin":1237,"end":1362},"obj":"Sentence"},{"id":"T101","span":{"begin":1364,"end":1406},"obj":"Sentence"},{"id":"T102","span":{"begin":1407,"end":1460},"obj":"Sentence"},{"id":"T103","span":{"begin":1462,"end":1485},"obj":"Sentence"},{"id":"T104","span":{"begin":1486,"end":1501},"obj":"Sentence"},{"id":"T105","span":{"begin":1503,"end":1522},"obj":"Sentence"},{"id":"T106","span":{"begin":1523,"end":1581},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Abbreviations\nCOVID-19 Coronavirus disease 2019\nSARS-COV-2 virus Severe acute respiratory syndrome coronavirus 2\nICU Intensive care unit\nIPA Invasive pulmonary aspergillosis\nIAA Influenza-associated aspergillosis\nARDS Acute respiratory distress syndrome\nh Hour\nBAL Broncho-alveolar lavage\nCT Computed tomography\nEORTC European Organization for Research and Treatment of Cancer\nAspICU Aspergillosis intensive care unit\nNo Number\nSD Standard deviation\nHEPA High-efficiency particulate air filters\nPublisher's Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\n\nAcknowledgements\nWe want to thank our entire ICU team for their unwavering commitment during these challenging times.\n\nAuthors’ contributions\nLR wrote the first draft of manuscript with input and revisions from NVR and NS. NS collected the data from the source documents. TVH and LR performed the literature search. PB and HD advised on the reporting of the clinical data; RN and HM on the reporting of the microbiological and infection prevention data. All authors had full access to all of the data. All authors read and approved the final manuscript.\n\nFunding\nNone.\n\nAvailability of data and materials\nThe datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.\n\nEthics approval and consent to participate\nPublication approval granted by the Ethics Committee.\n\nConsent for publication\nNot applicable.\n\nCompeting interests\nThe authors declare that they have no competing interests."}

LitCovid-PubTator

{"project":"LitCovid-PubTator","denotations":[{"id":"213","span":{"begin":23,"end":47},"obj":"Disease"},{"id":"215","span":{"begin":48,"end":58},"obj":"Species"},{"id":"217","span":{"begin":141,"end":173},"obj":"Disease"},{"id":"219","span":{"begin":174,"end":177},"obj":"Chemical"},{"id":"221","span":{"begin":199,"end":212},"obj":"Disease"},{"id":"223","span":{"begin":213,"end":217},"obj":"Disease"},{"id":"225","span":{"begin":218,"end":253},"obj":"Disease"},{"id":"227","span":{"begin":370,"end":376},"obj":"Disease"},{"id":"229","span":{"begin":428,"end":430},"obj":"Disease"},{"id":"232","span":{"begin":955,"end":957},"obj":"Disease"},{"id":"233","span":{"begin":1059,"end":1068},"obj":"Disease"}],"attributes":[{"id":"A213","pred":"tao:has_database_id","subj":"213","obj":"MESH:C000657245"},{"id":"A215","pred":"tao:has_database_id","subj":"215","obj":"Tax:2697049"},{"id":"A217","pred":"tao:has_database_id","subj":"217","obj":"MESH:D055744"},{"id":"A221","pred":"tao:has_database_id","subj":"221","obj":"MESH:D001228"},{"id":"A223","pred":"tao:has_database_id","subj":"223","obj":"MESH:D012128"},{"id":"A225","pred":"tao:has_database_id","subj":"225","obj":"MESH:D012128"},{"id":"A227","pred":"tao:has_database_id","subj":"227","obj":"MESH:D009369"},{"id":"A229","pred":"tao:has_database_id","subj":"229","obj":"MESH:D029461"},{"id":"A232","pred":"tao:has_database_id","subj":"232","obj":"MESH:D006816"},{"id":"A233","pred":"tao:has_database_id","subj":"233","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Abbreviations\nCOVID-19 Coronavirus disease 2019\nSARS-COV-2 virus Severe acute respiratory syndrome coronavirus 2\nICU Intensive care unit\nIPA Invasive pulmonary aspergillosis\nIAA Influenza-associated aspergillosis\nARDS Acute respiratory distress syndrome\nh Hour\nBAL Broncho-alveolar lavage\nCT Computed tomography\nEORTC European Organization for Research and Treatment of Cancer\nAspICU Aspergillosis intensive care unit\nNo Number\nSD Standard deviation\nHEPA High-efficiency particulate air filters\nPublisher's Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\n\nAcknowledgements\nWe want to thank our entire ICU team for their unwavering commitment during these challenging times.\n\nAuthors’ contributions\nLR wrote the first draft of manuscript with input and revisions from NVR and NS. NS collected the data from the source documents. TVH and LR performed the literature search. PB and HD advised on the reporting of the clinical data; RN and HM on the reporting of the microbiological and infection prevention data. All authors had full access to all of the data. All authors read and approved the final manuscript.\n\nFunding\nNone.\n\nAvailability of data and materials\nThe datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.\n\nEthics approval and consent to participate\nPublication approval granted by the Ethics Committee.\n\nConsent for publication\nNot applicable.\n\nCompeting interests\nThe authors declare that they have no competing interests."}